MSH2-deficient tumor cell lines have lost most of the ability to accurately repair plasmid DNA double-strand breaks through homologous recombination and increased susceptibility to cancer by promoting deletions or insertion mutations associated with DNA double-strand break repair [14]. The gene discussed is MSH2; the disease is cancer.